We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
iRobot Corporation (IRBT - Free Report) is one of the "stay at home" winners during the coronavirus pandemic. This Zacks Rank #1 (Strong Buy) saw third quarter revenue jump 43% year-over-year as consumers rushed out to buy the Roomba and other products.
iRobot designs and builds robots for us both inside and outside the home. It’s products include the home robot Roomba Robot Vacuum which debuted in 2002 as well as the Braava family of mopping robots.
Big Earnings Beat in the Third Quarter
On Oct 20, iRobot reported its third quarter results and beat the Zacks Consensus by 183%. It reported earnings of $2.58 versus the consensus of just $0.91.
Revenue jumped 43% to $413.1 million from $289.4 million in the year ago quarter.
The US saw 75% revenue growth with 22% in EMEA and 12% in Japan over the prior year.
Online was hot on the company’s website and app as well as on traditional retailers’ websites. It grew about 70% and represented approximately 60% of the entire quarter’s revenue.
Direct-to-consumer jumped 155% to $35 million versus the third quarter of last year.
Full Year Guidance Above Expectations
With a strong third quarter, the extension of its tariff exclusion until the end of the year and bullish orders for the upcoming holiday season, the company sees fiscal 2020 above its original 2020 guidance.
Earnings are now expected in the range of $3.43 to $3.53.
However, even with the analysts raising the Consensus, it is still falling a bit short with the Zacks Consensus jumping to $2.98 from $2.45 in the last week. I would expect the consensus to rise further from here.
That’s earnings growth of just 0.3% as the company made $2.97 last year, but look for it to move higher to be in line with the company’s guidance range.
Plenty of Cash and Teladoc Health Stock on Hand
As of Sep 26, 2020, iRobot had $357.3 million in cash, cash equivalents and short-term investments on hand. That’s up from $242.3 million as of June 27, 2020.
It received about $35 million in tariff-related refunds and approximately $52 million in Teladoc Health stock which it got in the third quarter when Teladoc Health acquired the company’s stake in InTouch Health.
iRobot’s Teladoc Health shares are subject to sales restrictions until early 2021.
iRobot has no debt but it does have access to a $150 million unsecured revolving line of credit.
Shares Soar in 2020
Wall Street has deemed iRobot a pandemic winner as its shares have soared 61.9% in 2020.
Shares aren’t cheap, on a P/E basis, with a forward P/E of 28.
But for investors looking for a company with no debt, cash on hand and a hot product for the home, iRobot is one to keep on your short list.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Bull of the Day: iRobot (IRBT)
iRobot Corporation (IRBT - Free Report) is one of the "stay at home" winners during the coronavirus pandemic. This Zacks Rank #1 (Strong Buy) saw third quarter revenue jump 43% year-over-year as consumers rushed out to buy the Roomba and other products.
iRobot designs and builds robots for us both inside and outside the home. It’s products include the home robot Roomba Robot Vacuum which debuted in 2002 as well as the Braava family of mopping robots.
Big Earnings Beat in the Third Quarter
On Oct 20, iRobot reported its third quarter results and beat the Zacks Consensus by 183%. It reported earnings of $2.58 versus the consensus of just $0.91.
Revenue jumped 43% to $413.1 million from $289.4 million in the year ago quarter.
The US saw 75% revenue growth with 22% in EMEA and 12% in Japan over the prior year.
Online was hot on the company’s website and app as well as on traditional retailers’ websites. It grew about 70% and represented approximately 60% of the entire quarter’s revenue.
Direct-to-consumer jumped 155% to $35 million versus the third quarter of last year.
Full Year Guidance Above Expectations
With a strong third quarter, the extension of its tariff exclusion until the end of the year and bullish orders for the upcoming holiday season, the company sees fiscal 2020 above its original 2020 guidance.
Earnings are now expected in the range of $3.43 to $3.53.
However, even with the analysts raising the Consensus, it is still falling a bit short with the Zacks Consensus jumping to $2.98 from $2.45 in the last week. I would expect the consensus to rise further from here.
That’s earnings growth of just 0.3% as the company made $2.97 last year, but look for it to move higher to be in line with the company’s guidance range.
Plenty of Cash and Teladoc Health Stock on Hand
As of Sep 26, 2020, iRobot had $357.3 million in cash, cash equivalents and short-term investments on hand. That’s up from $242.3 million as of June 27, 2020.
It received about $35 million in tariff-related refunds and approximately $52 million in Teladoc Health stock which it got in the third quarter when Teladoc Health acquired the company’s stake in InTouch Health.
iRobot’s Teladoc Health shares are subject to sales restrictions until early 2021.
iRobot has no debt but it does have access to a $150 million unsecured revolving line of credit.
Shares Soar in 2020
Wall Street has deemed iRobot a pandemic winner as its shares have soared 61.9% in 2020.
Shares aren’t cheap, on a P/E basis, with a forward P/E of 28.
But for investors looking for a company with no debt, cash on hand and a hot product for the home, iRobot is one to keep on your short list.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>